Roka Bioscience (ROKA) Misses Q1 EPS by 1c

Roka Bioscience (NASDAQ: ROKA) reported Q1 EPS of ($0.47), $0.01 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.56 million.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• S&P 500 may pull back before midterms, but Citi says buy the dip
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue